Med Chem Res (2011) 20:1158–1163
1163
Burns J, Yokota T, Ashihara H, Lean ME, Crozier A (2002) Plant
foods and herbal sources of resveratrol. J Agric Food Chem
50:3337–3340
block human platelet aggregation and eicosanoid synthesis
implications for protection against coronary heart disease. Clin
Chim Acta 235(2):207–219
Cirla A, Mann J (2003) Combretastatins: from natural products to
drug discovery. Nat Prod Rep 20:558–564
Griggs J, Metcalfe JC, Hesketh R (2001) Targeting tumour vascu-
lature: the development of combretastatin A4. Lancet Oncol
2:82–87
Prukała D (2006) Electron ionization mass spectrometric study of
N-substituted hydrazones of isomeric hydroxybenzaldehydes and
isomeric pyridinecarboxaldehydes bearing an N-(E)-stilbeny-
loxyalkylcarbonyltryptophyl substituent. Rapid Commun Mass
Spectrom 20(12):1965–1968
Gupta KC, Nigam RK, Srivastava N (1984) A new semi-stabilized
fluorinated ylid: p- fluorobenzylidene triphenyl-phosphorane.
Curr Sci 53(4):191–193
Rao GK, Venugopala KN (2007) Novel Schiff bases of 4-hydroxy-6-
carboxhydrazino benzofuran analogs: synthesis and pharmaco-
logical study. J Pharmacol Toxicol 2(5):481–488
´
Hart JH (1991) Role of phytostilbenes in decay and disease resistance.
Annu Rev Phytopathol 19:437–458
Rivillas-Acevedo L, Soriano-Garcıa M (2007) Antifungal activity of a
protein extract from Amaranthus hypochondriacus seeds. J Mex
Chem Soc 51(3):136–140
Roberti M, Pizzirani D, Simoni D, Rondanin R, Baruchello R, Bonora
C, Buscemi F, Grimaudo S, Tolomeo M (2003) Synthesis and
biological evaluation of resveratrol and analogues as apoptosis-
inducing agents. J Med Chem 46:3546–3554
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW,
Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC,
Pezzuto JM (1997) Cancer chemopreventive activity of resve-
ratrol, a natural product derived from grapes. Science 275:
218–220
Kang SS, Cuendet M, Endringer DC, Croy VL, Pezzuto JM, Lipton
MA (2009) Synthesis and biological evaluation of a library of
resveratrol analogues as inhibitors of COX-1, COX-2 and NF
kappaB. Bioorg Med Chem 17(3):1044–1054
Shastri RA, Varudkar JS (2009) Synthesis and antimicrobial activity
of 3-propene-1,2-benzisoxazole derivatives. Indian J Chem Sec
48B:1156–1160
Siegrist AE, Liechti P, Meyer HR, Weber K (1969) Anil-synthese. 3.
¨
Mitteilung [1] Uber die darstellung von styryl-derivaten aus
Knutson MD, Leeuwenburgh C (2008) Resveratrol and novel potent
activators of SIRT1: effects on aging and age-related diseases.
Nutr Rev 66:591–596
methyl-substituierten carbocyclischen aromaten. Helv Chim
Acta 52(8):2521–2554
1
´
Kvaran A, Konraðsson AE, Evans C, Geirsson JKF (2000) H-NMR,
Simoni D, Roberti M, Invidiata FP, Aiello E, Aiello S, Marchetti P,
Baruchello R, Eleopra M, Di Cristina A, Grimaudo S, Gebbia N,
Crosta L, Dieli F, Tolomeo M (2006) Stilbene-based anticancer
agents: resveratrol analogues active toward HL 60 leukemic cells
with a non-specific phase mechanism. Bioorg Med Chem Lett
16:3245–3248
Soleas GJ, Diamandis EP, Goldberg DM (1997) Resveratrol: a
molecule whose time has come? and gone? Clin Biochem 30:
91–113
UV-VIS spectroscopy and molecular mechanics calculations for
chlorine substituted stilbenes; conformational studies. J Mol
Struct 553:79–90
Lastra CA, Villegas I (2007) Resveratrol as an antioxidant and pro-
oxidant agent: mechanisms and clinical implications. Biochem
Soc Trans 35:1156–1160
Leifert WR, Abeywardena MY (2008) Cardioprotective actions of
grape polyphenols. Nutr Res 28:729–737
`
MacCarrone M, Lorenzon T, Guerrieri P, Finazzi Agro A (1999)
Szewczuk LM, Forti L, Stivala LA, Penning TM (2004) Resveratrol is
a peroxidase-mediated inactivator of COX-1 but not COX-2: a
mechanistic approach to the design of COX-1 selective agents.
J Biol Chem 279(21):22727–22737
Resveratrol prevents apoptosis in K562 cells by inhibiting
lipoxygenase and cyclooxygenase activity. Eur J Biochem 265:
27–34
Mokni M, Elkahoui S, Limam F, Amri M, Aouani E (2007) Effect of
resveratrol on antioxidant enzyme activities in the brain of
healthy rat. Neurochem Res 32:981–987
Traylor TG, Stewart KJ (1986) Mechanisms of arene exchange in
(arene)tricarbonylchromium compounds: intermolecular and
intramolecular exchanges in complexes of propenylbenzene,
stilbenes, and 1,1-diphenylethylene. J Am Chem Soc 108(22):
6977–6985
Udenigwe CC, Ramprasath VR, Aluko RE, Jones PJ (2008) Potential
of resveratrol in anticancer and anti-inflammatory therapy. Nutr
Rev 66:445–454
Moran BW, Anderson FP, Devery A, Cloonan S, Butler WE,
Varughese S, Draper SM, Kenny PTM (2009) Synthesis,
structural characterization and biological evaluation of fluori-
nated analogues of resveratrol. Bioorg Med Chem 17:4510–4522
Murata M, Kawakita K, Asana T, Watanabe S, Masuda Y (2002)
Rhodium- and ruthenium-catalyzed dehydrogenative borylation
of vinylarenes with pinacolborane: stereoselective synthesis of
vinylboronates. Bull Chem Soc Jpn 75(4):825–829
Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud
P (2008) Therapeutic potential of resveratrol in Alzheimer’s
disease. BMC Neurosci 9(2):S6
Norris JR, Ribbons DW, Kabelitz D (1972) Methods in microbiology.
Academic Press, London, p 216
Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM
(1995) The red wine phenolics trans-resveratrol and quercetin
Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q (2005) Anticancer
activity of resveratrol on implanted human primary. World J
Gastroenterol 11(2):280–284
123